Occult pelvic lymph node involvement in bladder cancer: implications for definitive radiation

Area of Science:

• Uro-oncology
• Radiation Oncology
• Surgical Pathology

Background:

• Accurate staging of bladder cancer is crucial for effective treatment planning.
• Identifying occult (hidden) lymph node metastasis is essential for optimizing radiation therapy (RT) and improving patient outcomes.
• Node-negative (N0) bladder cancer patients may still harbor microscopic disease in pelvic lymph nodes.

Purpose of the Study:

• To identify clinical factors predicting the presence and location of occult pelvic lymph nodes in clinically staged, node-negative bladder cancer patients.
• To inform radiation treatment planning (RTP) for urothelial carcinoma of the bladder.
• To assess the association between preoperative clinical variables and occult nodal involvement.

Main Methods:

• Retrospective review of 315 patients with clinically staged T1-T4N0 urothelial carcinoma of the bladder.
• Patients underwent radical cystectomy and pelvic lymphadenectomy.
• Logistic regression analysis evaluated associations between preoperative variables and occult pelvic/common iliac lymph node involvement; clinical target volumes (CTVs) were calculated.

Main Results:

• 81% (26%) of patients had involved pelvic lymph nodes; 38% (12%) had common iliac node involvement.
• Lymphovascular invasion (LVI) on biopsy was significantly associated with pelvic nodal involvement (OR 3.74) and marginally with common iliac nodes (OR 2.31).
• Involved nodal regions varied by CTV: 85.4% (whole bladder), 95.1% (small pelvis), 94.8% (extended pelvis) in muscle-invasive disease with LVI.

Conclusions:

• Occult pelvic lymph node metastasis is prevalent in bladder cancer, especially in patients with LVI.
• Radiation treatment planning should consider extended pelvic coverage, including common iliac nodes, for specific patient subsets.
• These findings aid in refining RT strategies for node-negative bladder cancer.